Quick info
4-FA (4-fluoramphetamine or 4-FMP) belongs to the phenethylamine group of substances and is pharmacologically related to amphetamine and methamphetamine. 4-FA has a stimulating and slightly euphoric effect and is one of the less researched new psychoactive substances.
4-FA has a stimulating effect on the central nervous system. In addition, there is a release of serotonin, which gives the effect an emotional, entactogenic component. The effect is described as a mixture of the effects of amphetamine and MDMA, but less intense. Further, it has performance-enhancing and mood-enhancing to euphoric effects. A suppression of hunger, thirst and fatigue as well as nausea is also reported. One has clear thoughts, reflects a lot and has a strong urge to communicate.
Onset of action:
Swallowed: 30-75 minutes
Snorted: 5-10 minutes
Duration of action:
Swallowed: 5-8 hours
Snorted: 3-5 hours
Swallowed
Light: 40-100 mg
Medium: 100-130 mg
Heavy: 130-150 mg
Snorted
Light: 10-30 mg
Medium: 30-70 mg
Heavy: 70-100 mg
Caution: the substance irritates the eyes, respiratory tract, skin and mucous membranes and should therefore only be swallowed. When snuffed, the nasal mucous membranes are very irritated and can still burn unpleasantly even after days.
manifestations
powder or crystals. Also in pills and capsule form.
Compared to other amphetamine derivatives and amphetamine-like substances, the increase in body temperature and activation of the chewing muscles (teeth grinding) do not seem to be as pronounced. Overdoses may cause headaches, moodiness, balance disorders, and sweating. Furthermore, panic attacks and anxiety up to paranoia are possible, and temporary hearing loss may also occur. Kidney/liver pain and discolored (brown) urine and yellowish skin have also been reported. In rare cases, epileptic seizures may occur. Some users report that headaches, circulatory problems, and depressive moods may occur in the days following consumption.
4-FA is a new psychoactive substance. To date, nothing is known about the exact mechanisms of action, toxicity and possible long-term effects. The current state of knowledge is based almost exclusively on reports from users.
LSD analogues are substances that are chemically very similar to LSD and can have comparable effects. Some of them have been known for a long time (e.g. ALD52, ETH-LAD, AL-LAD, PRO-LAD etc.) and have been studied pharmacologically as well as psychopharmacologically, at least in part. Others are newer "creations" (e.g. the derivatives 1P-LSD,1B-LSD, 1cP-LSD, 1V-LSDetc.), for which only few or no data are available. Certain LSD analogues can (still) be legally produced, traded and consumed in some countries, which is the main reason for their distribution.
Most LSD analogues are naturally different from LSD in their effect and/or potency (e.g. ETH-LAD, AL-LAD, LSZ etc.). In contrast, the so-called 1-acylated LSD compounds (e.g. 1P-LSD, 1V-LSD, 1B-LSD, ALD-52, etc.) are presumed, on the basis of pharmacological studies, to convert into LSD in the body (they function as so-called prodrugs) and thus have a comparable psychoactive effect to LSD.
In the case of prodrugs of LSD and LSD analogues, it has not been conclusively clarified whether, in addition to their psychoactive effect, they can produce other pharmacological effects. How potent these prodrugs are compared to the resulting substance (e.g., 1P-LSD to LSD), and to what extent a delay in onset of action occurs in each case, may be substance-dependent and cannot be generalized. Therefore, it is important to approach the dose/effect carefully to avoid overdoses.
If you or someone else needs urgent help after taking drugs or alcohol, call an ambulance on 144. Tell the emergency responders everything you know.
It could save lives.